Tumour‐associated macrophages act as a slow‐release reservoir of nano‐therapeutic Pt(IV) pro‐drug
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Therapeutic nanoparticles (TNPs) aim to deliver drugs more safely and effectively to cancers, yet clinical results have been unpredictable owing to limited in vivo understanding. Here we use single-cell imaging of intratumoral TNP pharmacokinetics and pharmacodynamics to better comprehend their heterogeneous behaviour. Model TNPs comprising a fluorescent platinum(IV) pro-drug and a clinically tested polymer platform (PLGA-b-PEG) promote long drug circulation and alter accumulation by directing cellular uptake toward tumour-associated macrophages (TAMs). Simultaneous imaging of TNP vehicle, its drug payload and single-cell DNA damage response reveals that TAMs serve as a local drug depot that accumulates significant vehicle from which DNA-damaging Pt payload gradually releases to neighbouring tumour cells. Correspondingly, TAM depletion reduces intratumoral TNP accumulation and efficacy. Thus, nanotherapeutics co-opt TAMs for drug delivery, which has implications for TNP design and for selecting patients into trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Miller et al. found a reduction in liver metastases due to enhanced delivery of nano‐encapsulated platinum in the TME via TAMs in a breast cancer mouse model [87].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
A global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491
The Chemistry of Fluorescent Bodipy Dyes: Versatility Unsurpassed
Ulrich, G., Ziessel, R., & Harriman, A. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200702070 · Cited by 3,161
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Self-citationMacrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Cited by
Items 301–400 of 448
Extracellular vesicles derived from macrophages: Current applications and prospects in tumors
Lou, K., Feng, S., Luo, H., Zou, J., Zhang, G., & Zou, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1097074 · Cited by 16
Factors Influencing the Delivery Efficiency of Cancer Nanomedicines
Ullah, R., Wazir, J., Khan, F. U., Diallo, M. T., Ihsan, A. U., Mikrani, R., Aquib, M., & Zhou, X. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01691-3 · Cited by 16
Deng, H. X., Yang, X., Wang, H., Gao, M., Zhang, Y., Liu, R., Xu, H., & Zhang, W. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121585 · Cited by 14
Progress in application of nanomedicines for enhancing cancer sono-immunotherapy
Zhao, H., Du, F., Xiang, X., Tang, Y., Feng, Z., Wang, Z., Rong, X., & Qiu, L. (2024) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2024.107105 · Cited by 14
“Tumor-associated macrophages (TAMs) were associated with TME [121].”
BackgroundBrüßeler, M., Zam, A., Moreno-Zafra, V., Rouatbi, N., Hassuneh, O. W. M., Marrocu, A., Liam‐Or, R., Abdel‐Bar, H. M., Walters, A. A., & Al‐Jamal, K. T. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00875 · Cited by 16
Cancer nanomedicine: Concepts, promises, and challenges
Zhu, C., Preis, E., Bakowsky, U., & Xia, Y. (2025) · Chem · doi:10.1016/j.chempr.2025.102706 · Cited by 17
Heck, J. G., Rox, K., Lünsdorf, H., Lückerath, T., Klaassen, N., Medina, E., Goldmann, O., & Feldmann, C. (2018) · ACS Omega · doi:10.1021/acsomega.8b00637 · Cited by 16
Nanotechnology in Radiation Oncology
Sun, B., Hagan, C. T., Caster, J. M., & Wang, A. Z. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.08.002 · Cited by 15
Feng, H., Kang, J., Qi, S., Kishimura, A., Mori, T., & Katayama, Y. (2021) · RSC Advances · doi:10.1039/d1ra06514a · Cited by 14
Impact of Tumor Barriers on Nanoparticle Delivery to Macrophages
Ouyang, B., Kingston, B. R., Poon, W., Zhang, Y.-N., Lin, Z. P., Syed, A. M., Couture‐Senécal, J., & Chan, W. C. W. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00905 · Cited by 14
Yang, Z., Li, W., Zhang, W., Zhang, M., He, J., Yu, Z., Sun, X., & Ni, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041241 · Cited by 14
“[36] designed a therapeutic regimen that used TAMs as a sustained-release library of platinum (IV) precursors for nanotherapy.”
In Vitro and In Vivo Tumor Models for the Evaluation of Anticancer Nanoparticles
Abreu, T. R., Biscaia-Caleiras, M., Gonçalves, N., Fonseca, N. A., & Moreira, J. N. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-58174-9_12 · Cited by 18
Lammers, T. (2020) · Nature Materials · doi:10.1038/s41563-020-00855-7 · Cited by 14
Ravi, H., Arias, A., Costello, J. R., Han, H. S., Jeong, D. K., Klinz, S. G., Sachdev, J. C., Korn, R. L., & Raghunand, N. (2023) · Radiology Imaging Cancer · doi:10.1148/rycan.220022 · Cited by 16
Shang, L., Xie, Q., Yang, C., Kong, L., & Zhang, Z. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c10237 · Cited by 15
Salah, A., Li, Y., Wang, H., Qi, N., & Wu, Y. (2021) · DNA and Cell Biology · doi:10.1089/dna.2020.6087 · Cited by 14
“Once in place and under hypoxic tumor conditions, they unload the antineoplastic agents, leading to tumor remission (Choi et al. , 2012a; Miller et al. , 2015).”
Designing and Immunomodulating Multiresponsive Nanomaterial for Cancer Theranostics
Khan, A., Dias, F., Neekhra, S., Singh, B., & Srivastava, R. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2020.631351 · Cited by 14
Shin, Y. B., Choi, J., Shin, D. H., & Lee, J. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s394712 · Cited by 13
Investigation into the Biological Impact of Block Size on Cathepsin S-Degradable HPMA Copolymers
Fan, W. Q., Zhang, W., Jia, Y., Brusnahan, S. K., & Garrison, J. C. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01038 · Cited by 13
Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies
Bhavsar, C., Momin, M. M., Khan, T. A., & Omri, A. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1424825 · Cited by 13
Microfluidic production of inorganic nanomaterials for biomedical applications
Sebastián, V., & Arruebo, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812659-2.00008-9 · Cited by 13
Kaiser, Y., Garris, C., Marinari, E., Kim, H. S., Oh, J., Pédard, M., Halabi, E. A., Choi, M., Parvanian, S., Köhler, R. H., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01533-2 · Cited by 17
Self-citationWang, T.-Q., Mu, W., Li, F., Zhang, J., Hou, T., Pang, X., Yin, X., & Zhang, N. (2020) · Nanoscale · doi:10.1039/d0nr04025h · Cited by 9
Shimoyama, S., Okada, K., Kimura, T., Morohashi, Y., Nakayama, S., Kemmochi, S., Makita-Suzuki, K., Matulonis, U. A., & Mori, M. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0099 · Cited by 11
“The internalization of nanoparticles by TAMs and the activation of glutaminolysis have been demonstrated in both preclinical models and in patient tumor biopsies (23, 24, 27, 28, 38).”
Leveraging insights from cancer to improve tuberculosis therapy
Datta, M., Via, L. E., Dartois, V. A., Xu, L., Barry, C. E., & Jain, R. K. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.07.011 · Cited by 12
A review on biomacromolecular ligand-directed nanoparticles: New era in macrophage targeting
Swami, R., Popli, P., Sal, K., Challa, R. R., Vallamkonda, B., Garg, M., & Dora, C. P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141740 · Cited by 14
Stimuli-Responsive Nanomaterials for Drug Delivery
López‐Saucedo, F., Flores‐Rojas, G. G., Melendez‐Ortiz, H. I., Morfín-Gutiérrez, A., Luna-Straffon, M. A., & Bucio, E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814031-4.00014-3 · Cited by 13
Rein, V., Meschkov, A., Hagens, K., Redinger, N., Schepers, U., Mehlhorn, H., Schaible, U. E., & Feldmann, C. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201900543 · Cited by 11
Jeganathan, S., Budziszewski, E., Hernandez, C., Dhingra, A., & Exner, A. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-63636-x · Cited by 11
Delineating the tumour microenvironment response to a lipid nanoparticle formulation
Ngai, J., MacMillan, P., Kingston, B. R., Lin, Z. P., Ouyang, B., & Chan, W. C. W. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.021 · Cited by 14
Dinh, T., Zia, Q., Zubair, S., Stapleton, P. D., Singh, R., Owais, M., & Somavarapu, S. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.02.003 · Cited by 12
Metal Complexes as Drugs and Therapeutic Agents
Zhou, Y. Y., Ip, T. K.-Y., Zhang, Q., Li, H., & Sun, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102688-5.00018-0 · Cited by 10
Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell‐Based Methods
Joshi, B. P., Hardie, J. M., & Farkas, M. E. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201706180 · Cited by 10
Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma
Chillà, A., Margheri, F., Biagioni, A., Rosso, T. D., Fibbi, G., Rosso, M. D., & Laurenzana, A. (2020) · Cancers · doi:10.3390/cancers12071771 · Cited by 10
“[85] have prepared therapeutic NPs comprising a fluorescent platinum(IV) pro-drug and a clinically tested polymer platform (PLGA-b-PEG) that promote long drug circulation and accumulation by directing cellular uptake toward tumor-associated macrophages (TAMs).”
BackgroundEngineering immunity using metabolically active polymeric nanoparticles
Griffin, K. V., Saunders, M. N., Lyssiotis, C. A., & Shea, L. D. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.11.016 · Cited by 10
Nomadic Nanomedicines: Medicines Enabled by the Paracrine Transfer Effect
Paranandi, K. S., Amar‐Lewis, E., Mirkin, C. A., & Artzi, N. (2025) · ACS Nano · doi:10.1021/acsnano.4c15052 · Cited by 9
Developing bioinspired delivery systems for enhanced tumor penetration of macromolecular drugs
Yang, J. P., Zeng, Z., Liu, Y., Li, Y., & Xu, X. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113845 · Cited by 11
Matthew, S. A. L., & Seib, F. P. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400130 · Cited by 11
Жукова, О. В., Kovaleva, T. F., Архипова, Е. В., Ryabov, S. A., & Mukhina, I. V. (2020) · Biomedical Reports · doi:10.3892/br.2020.1354 · Cited by 9
Wang, F., Hou, W., Xiao, C., Hao, Y., Su, N., Deng, Y. L., Wang, J., Yu, L., Xie, J.-M., Xiong, J., et al. (2021) · Nanoscale · doi:10.1039/d1nr04181a · Cited by 9
Theranostics: Agents for Diagnosis and Therapy
Nicolson, F., & Kircher, M. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00040-5 · Cited by 10
Rodell, C. B., Baldwin, P., Fernandez, B., Weissleder, R., Sridhar, S., & Dubach, J. M. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000125 · Cited by 10
Self-citationMcMahon, N. P., Solanki, A., Wang, L. G., Montaño, A. R., Jones, J. A., Samkoe, K. S., Tichauer, K. M., & Gibbs, S. L. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01589-x · Cited by 8
Ultrasound-activated poly(butyl cyanoacrylate) microbubbles enhance the therapeutic effect of Doxil
Blöck, J., Imschweiler, L., Mihyar, R., Chen, J., Barmin, R. A., Koletnik, S., Pallares, R. M., Lammers, T., Rix, A., & Kiessling, F. M. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107916 · Cited by 8
Cryer, A. M., Dosta, P., Dion, M. Z., Soto, L. D. L. P., Amar‐Lewis, E., Carmona, G. G. D. L., Perez, A. A. E., Aguilar, D. F. R., Sanchez-Huerta, T. M., Ruiz, B. N., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2409556122 · Cited by 10
Li, H., Luo, Q., Zhu, H., Li, Z., Wang, X., Roberts, N., Zhang, H., Gong, Q., Gu, Z., & Luo, K. (2020) · Polymer Chemistry · doi:10.1039/d0py01133a · Cited by 8
Mechanisms Underlying Tumor-Associated Macrophages (TAMs)-Facilitated Metastasis
Aleebrahim‐Dehkordi, E., Deravi, N., Fallahi, M. S., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_66-1 · Cited by 9
Macrophage imaging and subset analysis using single-cell RNA sequencing
Arlauckas, S. P., Oh, N., Li, R., Weissleder, R., & Miller, M. A. (2020) · Nanotheranostics · doi:10.7150/ntno.50185 · Cited by 8
“In follow-up, MΦ depletion decreased intratumoral accumulation of therapeutic nanoparticles and resulted in tumor growth [7].”
BackgroundInfluentialSelf-citationNanoparticles targeting tumor-associated macrophages: A novel anti-tumor therapy
Chen, S., Qin, F., Wang, M., Wei, Y., Qian, Z., & Wei, X. (2021) · Nano Research · doi:10.1007/s12274-021-3781-5 · Cited by 8
Ban, G., Chen, Y., Liang, Y., Wang, X., Ding, D., Liu, R., Jia, J., Zhao, R., Wang, C., & Li, N. (2025) · Drug Delivery · doi:10.1080/10717544.2024.2445257 · Cited by 7
“PtNPs prone to agglomeration may disrupt organelle function within lung cells, warranting attention (Miller et al., 2015; lambert & Sørensen, 2018; Pawar et al., 2021; ismail et al., 2022). in several experiments, it has been found that Pt particles in metal PtNPs can mediate DNA strand breaks,…”
Xia, R., Liang, J., Ma, J., Du, X., Ma, L., Han, X., Wang, Y., Qin, J., & Yan, L. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1618903 · Cited by 9
“Studies con fi rmed that intravenously delivered nanoparticles are highly internalized by perivascular macrophages at tumor sites and retained intracellularly for prolonged periods (61).”
Meneses, D. D., Figueroa‐Valdés, A. I., Georges, N., Tobar, H. E., & Alcayaga‐Miranda, F. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10349 · Cited by 7
“that nanoparticles or nanovesicles of 100 nm in size are selectively retained in tumor tissue through the mechanism called enhanced permeation and retention (EPR) effect.(13,14)”
BackgroundBilbao‐Asensio, M., Ruiz‐de‐Angulo, A., Arguinzoniz, A. G., Cronin, J., Llop, J., Zabaleta, A., Michue‐Seijas, S., Sosnowska, D., Arnold, J. N., & Rivas, J. C. M. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200179 · Cited by 7
Passeri, G., Vincent, R. A., Xiao, Z., Northcote‐Smith, J., & Suntharalingam, K. (2022) · ChemMedChem · doi:10.1002/cmdc.202200599 · Cited by 8
A magnetism/laser-auxiliary cascaded drug delivery to pulmonary carcinoma
Lin, J., Yin, Q., Chen, B., Zhang, H., Mei, D., Fu, J., He, B., Zhang, H., Dai, W., Wang, X., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.017 · Cited by 7
Visible light-activatable platinum( iv ) prodrugs harnessing CD36 for ovarian cancer therapy
Jayawardhana, A. M. D. S., Bhandari, S., Kaspi, A. W., Kshetri, M. B., Qiu, Z., Cheline, M., Shen, H., Dunietz, B. D., & Zheng, Y. (2023) · Dalton Transactions · doi:10.1039/d3dt01292a · Cited by 7
Self-citationCai, Y., Zhang, Z., Lu, Y., Shen, S., Lu, H., He, H., & Wu, W. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114759 · Cited by 8
McMahon, N. P., Solanki, A., Wang, L. G., Montaño, A. R., Jones, J. A., Samkoe, K. S., Tichauer, K. M., & Gibbs, S. L. (2024) · Theranostics · doi:10.7150/thno.93256 · Cited by 6
“Numerous small molecule drugs have been labeled with, for example, fluorescent, biotin and photoclickable tags to facilitate direct visualization of drug tissue distribution and target engagement [17, 26-29].”
BackgroundYamashita, S., Imanishi, A., Ueki, S., Okamoto, S., Kimura, S., & Kiriyama, A. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01171 · Cited by 6
Littrell, C. A., Takacs, G. P., Sankara, C. S., Sherman, A., Rubach, K. A., Garcia, J. S., Bell, C. A., Lnu, T., Harrison, J. K., & Zhang, F. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.003 · Cited by 7
Rizzo, L. Y., Lorenzi, F. D., von Stillfried, S. F., Dadfar, S. M., Hu, Q., Tiwari, S., Glüer, C., Thewissen, M. M., Gremse, F., Rütten, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116086 · Cited by 7
Krishnan, S., Jayanthi, N. N., Vajravelu, L. K., & Santhiya, D. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04497-8 · Cited by 5
“Establishing well-defined regulatory frameworks is equally important to demonstrate their efficacy in treating MRD infections in critical care settings. is essential to determine the long-term immune effects of AMP-based nanomedicines (Miller et al. 2015 ).”
On the uncertainty of the correlation between nanoparticle avidity and biodistribution
Zimmer, O., & Göpferich, A. M. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114240 · Cited by 7
Archer, P. A., Heiler, A. J., Bourque, A. R., Alapan, Y., & Thomas, S. N. (2024) · Biomaterials Science · doi:10.1039/d4bm00910j · Cited by 6
Picardi, M., Vincenzi, A., Giordano, C., Fazio, L. D., Pugliese, N., Scarpa, A., Vigliar, E., Troncone, G., Russo, D., Mascolo, M., et al. (2024) · Hematological Oncology · doi:10.1002/hon.70003 · Cited by 6
“Liposomal doxorubicin acts as a slow‐release reservoir with prolonged powerful tumor-icidal effects specifically inside the neoplastic tissue, that is, within tumor‐associated macrophages (TAMs) of the lymph-adenopathy microenvironment [12].”
Zhou, Q., Ma, H., Xu, H., Bai, Y., Tan, C., Su, Y.-W., Li, Y., Ying, X., & Zheng, Y. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00024 · Cited by 5
Self-citationSaladino, G. M. (2026) · RSC Advances · doi:10.1039/d5ra08785f · Cited by 5
“89 Smith et al. studied the delivery of single-walled carbon nanotubes (SWNTs) functionalized with the RGD peptide (RGD-SWNTs) to xenogra ed human glioblastoma tumor cells with a dorsal skinfold chamber.”
Picardi, M., Giordano, C., Pugliese, N., Mascolo, M., Varricchio, S., Troncone, G., Vigliar, E., Bellavicine, C., Lamagna, M., Lisi, D., et al. (2024) · Hematological Oncology · doi:10.1002/hon.3247 · Cited by 5
RetractedKutlu, E., Emen, F. M., Kısmalı, G., Kınaytürk, N. K., Karaçolak, A. İ., Kılıç, D., Ali, M. A., Kutlu, H. M., & Demirdöğen, R. E. (2021) · Polyhedron · doi:10.1016/j.poly.2021.115492 · Cited by 5
Therapeutic effect of indirubin-loaded bovine serum albumin nanoparticules on ulcerative colitis
Yu, G., Zhou, L., Liu, X., Liu, B., Lai, X., Xu, C.-L., Long, M.-Y., Zhu, Y.-M., Wang, J., & Li, M. (2022) · Biomaterials Science · doi:10.1039/d1bm01896e · Cited by 5
Chen, L., Chen, D., Jiang, Y., Zhang, J., Yu, J., DuFort, C. C., Hingorani, S. R., Zhang, X., Wu, C., & Chiu, D. T. (2019) · Angewandte Chemie · doi:10.1002/ange.201902077 · Cited by 5
Fu, J., Huang, S., Zhang, A., Shi, R., Wei, Y., He, S., Huang, S., Li, L., Sun, X., Gong, T., et al. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101413 · Cited by 5
“…i) Tumor-associated macrophages (TAMs): TAMs naturally accumulate at tumor sites and can serve as “local drug depots” for sustained payload release [40]. ii) Chimeric antigen receptor macrophages (CAR-Ms): these macrophages are engineered using chimeric adenoviral vectors to express CARs, enabling…”
PEGylation strategies for enhanced nanoparticle delivery to tumor‐associated immune cells
Cahn, D., Pal, S., Stern, A., Patel, N. L., Gower, T., Kapnick, S. M., Jewell, C. M., Duncan, G. A., & Wolf, M. T. (2025) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70098 · Cited by 8
“21,22 Neutrophils have been utilized for targeting NPs to the TME since they gravitate to inflammatory sites such as the TME and are the most abundant leukocyte found in the blood-stream.”
Sardar, M. S., Kashinath, K. P., Gupta, U., Roy, S., & Kaity, S. (2024) · Polymers for Advanced Technologies · doi:10.1002/pat.6461 · Cited by 4
Picardi, M., Giordano, C., Pugliese, N., Mascolo, M., Varricchio, S., Troncone, G., Vigliar, E., Bellavicine, C., Lamagna, M., Lisi, D., et al. (2023) · Hematological Oncology · doi:10.1002/hon.3242 · Cited by 4
Strategies for ligand-installed nanocarriers
Miyazaki, T., Nakagawa, Y., & Cabral, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821506-7.00024-7 · Cited by 5
Challenges and Future Opportunities of Nanomedicine in Cancer Therapy
Narayan, S. (2021) · Springer eBooks · doi:10.1007/978-981-15-7564-8_10 · Cited by 4
Vrouwe, J. P. M., Kamerling, I. M. C., van Esdonk, M. J., Metselaar, J. M., Stuurman, F. E., van der Pluijm, G., Burggraaf, J., & Osanto, S. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.845 · Cited by 4
“Any adverse event 5 (100) 0 (0) 4 (100) 1 (25)”
InfluentialMacrophage‐Anchored Nanofibers with Supramolecular Phenolic Gates for pH‐Responsive Chemotherapy
Yu, R., Guo, T., Zhu, Z., Shi, J. M., Lin, S., Lan, J., & Shang, J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202504208 · Cited by 3
Ranjini Jenifer, R., Choudhury, B., Alam, M. M., Balamurali, M. M., & Chanda, K. (2025) · Future Medicinal Chemistry · doi:10.1080/17568919.2025.2491303 · Cited by 3
Barnes, A., Gaikwad, H. K., Siegel, D. J., Angarita, D., Nebbia, M., Anchordoquy, T. J., Bourne, D. W. A., Stewart, M., Yıldırım, A., Cota, M. M. F., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c10594 · Cited by 3
Novel Anthracycline Utorubicin for Cancer Therapy
Simón‐Gracia, L., Sidorenko, V., Uustare, A., Ogibalov, I., Tasa, A., Tshubrik, O., & Teesalu, T. (2021) · Angewandte Chemie · doi:10.1002/ange.202016421 · Cited by 3
The Lymphatic Endothelium in the Context of Radioimmuno-Oncology
Suárez, L., Rodriguez-Ruiz, M. E., & Rouzaut, A. (2022) · Cancers · doi:10.3390/cancers15010021 · Cited by 4
“In this sense, accumulation of TAMs in the vicinity of the microvasculature of irradiated tumors has been used as a therapeutic strategy to increment the success of the administration of drug-loaded nanoparticles loaded [144,145].”
MethodMacrophages mediated biomimetic drug delivery systems
Sun, X., Zhu, D., & Cai, Y. (2018) · Journal of Nanomedicine · doi:10.33582/2578-8760/1003 · Cited by 3
Repurposing Tamoxifen for Tumor Microenvironment Priming and Enhanced Tumor‐Targeted Drug Delivery
Biancacci, I., Santis, D. D., Rama, E., Benderski, K., Momoh, J., Pohlberger, R. F., Moeckel, D., Kaps, L., Rijcken, C. J. F., Prakash, J., et al. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300098 · Cited by 4
Yamashita, S., Kume, A., Tsujimoto, N., Nozaki, S., Kimura, S., & Kiriyama, A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105244 · Cited by 3
Harnessing Microbial Effectors for Macrophage-Mediated Drug Delivery
Staden, A. D. P. V., Visser, J. G., Powrie, Y. S. L., & Smith, C. (2024) · ACS Omega · doi:10.1021/acsomega.3c10519 · Cited by 3
Engineering Novel Amphiphilic Platinum(IV) Complexes to Co-Deliver Cisplatin and Doxorubicin
Jogadi, W., Kshetri, M. B., Alqarni, S., Sharma, A., Cheline, M., Amin, M. A., Sheets, C., Nsoure-Engohang, A., & Zheng, Y. (2024) · Molecules · doi:10.3390/molecules29174095 · Cited by 3
“These Pt complexes exhibit remarkable stability in whole human blood, reducing their rate of reduction by reducing agents, and possess unique cancer cell targeting capabilities and mechanisms of action [23,28].”
BackgroundSelf-citationOh, N., & Kim, J. Y. (2025) · ACS Nano · doi:10.1021/acsnano.5c02283 · Cited by 3
Al‐Dhubiab, B. E., & Almuqbil, R. M. (2025) · Pharmaceuticals · doi:10.3390/ph18071057 · Cited by 4
“Then, TAMs gradually secrete their DNA-damaging platinum payload into neighbouring tumour cells [64].”
Picardi, M., Vincenzi, A., Pugliese, N., Giordano, C., Prastaro, M., Esposito, R., & Pane, F. (2025) · HemaSphere · doi:10.1002/hem3.70240 · Cited by 2
Qi, M., Ye, Y., Xu, Y., Lei, Q., Zhang, F., Chen, Z., Cheng, J., Cao, L., Liu, Y., Liu, Y., et al. (2025) · Nano Research · doi:10.26599/nr.2025.94908241 · Cited by 2
How Key in vivo Models Can Advance Anticancer Nanotherapeutics
Radha, G., & Chithrani, D. B. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s558763 · Cited by 3
“98 These combined ECM and macrophage-mediated barriers explain why NP accumulation rarely correlates with therapeutic efficacy in immunocompetent models and highlight the need to interpret in vivo delivery within the context of both immune surveillance and tumor microenvironment architecture.”
Delivery of Cancer Nanotherapeutics
Chung, B. L., Kaplinsky, J., Langer, R., & Kamaly, N. (2018) · Bioanalysis · doi:10.1007/978-3-030-01775-0_8 · Cited by 2
Image-guided cancer immunotherapy
Ng, T. S. C., & Miller, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90949-5.00013-9 · Cited by 2
Self-citationNavigating the nanoscale: Principles of body navigation
Abbasi, S., Dirisala, A., Carter, D. A. G., Paraiso, W. K. D., Li, J., & Tockary, T. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-823994-0.00002-5 · Cited by 2
Kshetri, M. B., Jogadi, W., Alqarni, S., Datta, P., Cheline, M., Sharma, A., Betters, T., Broyles, D., & Zheng, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713301 · Cited by 2
“FALPs have shown potent in vitro activity against a broad range of cancer types and promising in vivo efficacy in various mouse models [42].”
Self-citationManipulation of macrophage phagocytosis - development of an endogenous delivery system
Visser, J. G. (2020) · SUNScholar (Stellenbosch University) · Cited by 2
[Advances in nanoparticle-targeting tumor associated macrophages for cancer imaging and therapy].
Fengliang, G., Guping, T., & Qinglian, H. U. (2017) · PubMed Central · doi:10.3785/j.issn.1008-9292.2017.04.08 · Cited by 1
Recent Advances and Clinical Approach to Cancer Treatment with Nanotechnology Derived Biomolecule
Singh, A. P., Akhtar, W., Alam, S., & Naziya, N. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385297455240508055620 · Cited by 1
Metadata
- Authors
- Miller, M. A., Zheng, Y.-R., Gadde, S., Pfirschke, C., Zope, H., Engblom, C., Kohler, R. H., Iwamoto, Y., Yang, K. S., Askevold, B., Kolishetti, N., Pittet, M., Lippard, S. J., Farokhzad, O. C., & Weissleder, R.
- Affiliations
- Harvard University (US)
- Massachusetts Institute of Technology (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weissleder, Ralph
- ORCID
- Venue
- Nature Communications
- Published
- 2015-10-27
- Volume
- 6
- Issue
- 1
- Pages
- 8692-8692
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4711745
- OpenAlex
- W1874889006
- Cited by
- 441
- References
- 70
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 38 · 2023: 40 · 2022: 40 · 2021: 46 · 2020: 62 · 2019: 55 · 2018: 48 · 2017: 42 · 2016: 23
- FWCI
- 13.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- Deutsche Forschungsgemeinschaft (PF809/1-1, CA034992)
- National Institutes of Health (CA151884, U54-CA151884, CA034992, CA139980, PO1-CA139980)
- National Cancer Institute (CA-034992, CA139980, P50CA086355, R01CA164448, U54CA151884, P01CA139980, R37CA034992, CA151884, R01CA034992, P30CA014051, T32CA079443)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- tumour-associated macrophages, nanotherapeutics, pharmacodynamics, single-cell imaging, DNA damage response, slow drug release, TAM depletion, nanoparticle accumulation, cancer nanomedicine
- MeSH terms
- Animals, Antineoplastic Agents, Female, Humans, Macrophages, Mice, Inbred C57BL, Mice, Nude, Neoplasms, Platinum, Prodrugs, Drug Delivery Systems, Cell Line, Tumor, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.